Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meltzer

Showing results (581-590 of 614) with videos related to

Pageof 62
Sort By:
Cell Host & Microbe|May 11, 2018
Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus EvolutionAlberto Peretti, Eileen M Geoghegan, Diana V Pastrana, et al.
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment responseRomi Biswas, Shaojian Gao, Constance M Cultraro, et al.
Nature Communications|July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatmentJoo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trialAriel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Cancer Cell|February 15, 2011
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcomaBrian P Rubin, Koichi Nishijo, Hung-I Harry Chen, et al.
Nature Communications|June 23, 2023
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complexYilun Sun, Simone A Baechler, Xiaohu Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinomaToni K Choueiri, Ulka Vaishampayan, Jonathan E Rosenberg, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, David VanderWeele, Ravi A Madan, et al.
Nature Medicine|January 16, 2018
Positively selected enhancer elements endow osteosarcoma cells with metastatic competenceJames J Morrow, Ian Bayles, Alister P W Funnell, et al.
Nature Medicine|April 11, 2018
Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competenceJames J Morrow, Ian Bayles, Alister P W Funnell, et al.
Pageof 62

Showing results (581-590 of 614) with videos related to

Sort By:
Pageof 62
Cell Host & Microbe|May 11, 2018
Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus EvolutionAlberto Peretti, Eileen M Geoghegan, Diana V Pastrana, et al.
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment responseRomi Biswas, Shaojian Gao, Constance M Cultraro, et al.
Nature Communications|July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatmentJoo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trialAriel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Cancer Cell|February 15, 2011
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcomaBrian P Rubin, Koichi Nishijo, Hung-I Harry Chen, et al.
Nature Communications|June 23, 2023
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complexYilun Sun, Simone A Baechler, Xiaohu Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinomaToni K Choueiri, Ulka Vaishampayan, Jonathan E Rosenberg, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, David VanderWeele, Ravi A Madan, et al.
Nature Medicine|January 16, 2018
Positively selected enhancer elements endow osteosarcoma cells with metastatic competenceJames J Morrow, Ian Bayles, Alister P W Funnell, et al.
Nature Medicine|April 11, 2018
Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competenceJames J Morrow, Ian Bayles, Alister P W Funnell, et al.
Pageof 62